215 related articles for article (PubMed ID: 24115264)
1. Investigating alternatives to the fish early-life stage test: a strategy for discovering and annotating adverse outcome pathways for early fish development.
Villeneuve D; Volz DC; Embry MR; Ankley GT; Belanger SE; Léonard M; Schirmer K; Tanguay R; Truong L; Wehmas L
Environ Toxicol Chem; 2014 Jan; 33(1):158-69. PubMed ID: 24115264
[TBL] [Abstract][Full Text] [Related]
2. Adverse outcome pathways during early fish development: a conceptual framework for identification of chemical screening and prioritization strategies.
Volz DC; Belanger S; Embry M; Padilla S; Sanderson H; Schirmer K; Scholz S; Villeneuve D
Toxicol Sci; 2011 Oct; 123(2):349-58. PubMed ID: 21750347
[TBL] [Abstract][Full Text] [Related]
3. Comparative Assessment of the Sensitivity of Fish Early-Life Stage, Daphnia, and Algae Tests to the Chronic Ecotoxicity of Xenobiotics: Perspectives for Alternatives to Animal Testing.
Teixidó E; Leuthold D; de Crozé N; Léonard M; Scholz S
Environ Toxicol Chem; 2020 Jan; 39(1):30-41. PubMed ID: 31598995
[TBL] [Abstract][Full Text] [Related]
4. Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: II. A focus on growth impairment in fish.
Groh KJ; Carvalho RN; Chipman JK; Denslow ND; Halder M; Murphy CA; Roelofs D; Rolaki A; Schirmer K; Watanabe KH
Chemosphere; 2015 Feb; 120():778-92. PubMed ID: 25456049
[TBL] [Abstract][Full Text] [Related]
5. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
[TBL] [Abstract][Full Text] [Related]
6. A high-level overview of the OECD AOP Development Programme.
Chauhan V; Hamada N; Wilkins R; Garnier-Laplace J; Laurier D; Beaton D; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1704-1713. PubMed ID: 35938955
[TBL] [Abstract][Full Text] [Related]
7. Baseline characteristics and statistical implications for the OECD 210 fish early-life stage chronic toxicity test.
Oris JT; Belanger SE; Bailer AJ
Environ Toxicol Chem; 2012 Feb; 31(2):370-6. PubMed ID: 22095530
[TBL] [Abstract][Full Text] [Related]
8. Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.
Becker RA; Ankley GT; Edwards SW; Kennedy SW; Linkov I; Meek B; Sachana M; Segner H; Van Der Burg B; Villeneuve DL; Watanabe H; Barton-Maclaren TS
Regul Toxicol Pharmacol; 2015 Aug; 72(3):514-37. PubMed ID: 25863193
[TBL] [Abstract][Full Text] [Related]
9. Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale.
Halappanavar S; van den Brule S; Nymark P; Gaté L; Seidel C; Valentino S; Zhernovkov V; Høgh Danielsen P; De Vizcaya A; Wolff H; Stöger T; Boyadziev A; Poulsen SS; Sørli JB; Vogel U
Part Fibre Toxicol; 2020 May; 17(1):16. PubMed ID: 32450889
[TBL] [Abstract][Full Text] [Related]
10. The potential of AOP networks for reproductive and developmental toxicity assay development.
Knapen D; Vergauwen L; Villeneuve DL; Ankley GT
Reprod Toxicol; 2015 Aug; 56():52-5. PubMed ID: 25889759
[TBL] [Abstract][Full Text] [Related]
11. An AOP-based alternative testing strategy to predict the impact of thyroid hormone disruption on swim bladder inflation in zebrafish.
Stinckens E; Vergauwen L; Ankley GT; Blust R; Darras VM; Villeneuve DL; Witters H; Volz DC; Knapen D
Aquat Toxicol; 2018 Jul; 200():1-12. PubMed ID: 29702435
[TBL] [Abstract][Full Text] [Related]
12. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
Sachana M; Willett C; Pistollato F; Bal-Price A
Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
[TBL] [Abstract][Full Text] [Related]
13. Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology.
Groh KJ; Carvalho RN; Chipman JK; Denslow ND; Halder M; Murphy CA; Roelofs D; Rolaki A; Schirmer K; Watanabe KH
Chemosphere; 2015 Feb; 120():764-77. PubMed ID: 25439131
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of fish early life stage tests-Association of toxic ratios and acute-to-chronic ratios with modes of action.
Scholz S; Schreiber R; Armitage J; Mayer P; Escher BI; Lidzba A; Léonard M; Altenburger R
Environ Toxicol Chem; 2018 Apr; 37(4):955-969. PubMed ID: 29350428
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Adverse outcome pathway development from protein alkylation to liver fibrosis.
Horvat T; Landesmann B; Lostia A; Vinken M; Munn S; Whelan M
Arch Toxicol; 2017 Apr; 91(4):1523-1543. PubMed ID: 27542122
[TBL] [Abstract][Full Text] [Related]
17. Semantic characterization of adverse outcome pathways.
Wang RL
Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
[TBL] [Abstract][Full Text] [Related]
18. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network.
Tollefsen KE; Alonzo F; Beresford NA; Brede DA; Dufourcq-Sekatcheff E; Gilbin R; Horemans N; Hurem S; Laloi P; Maremonti E; Oughton D; Simon O; Song Y; Wood MD; Xie L; Frelon S
Int J Radiat Biol; 2022; 98(12):1816-1831. PubMed ID: 35976054
[TBL] [Abstract][Full Text] [Related]
19. AOPERA: A proposed methodology and inventory of effective tools to link chemicals to adverse outcome pathways.
Rycroft TE; Foran CM; Thrash A; Cegan JC; Zollinger R; Linkov I; Perkins EJ; Garcia-Reyero N
ALTEX; 2020; 37(1):64-74. PubMed ID: 31453632
[TBL] [Abstract][Full Text] [Related]
20. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation.
Chauhan V; Hamada N; Monceau V; Ebrahimian T; Adam N; Wilkins RC; Sebastian S; Patel ZS; Huff JL; Simonetto C; Iwasaki T; Kaiser JC; Salomaa S; Moertl S; Azimzadeh O
Int J Radiat Biol; 2021; 97(11):1516-1525. PubMed ID: 34402738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
